IRE favicon

Shop

Resource ID: #18096
Subject: Pharmaceuticals
Source: Wall Street Journal (New York)
Affiliation: 
Date: Jan. 10

Description

The Wall Street Journal analyses the survival of Merck & Co. at the time when it is gradually losing its exclusive rights to several of its best-selling drugs. The story finds that the key for Merck's success is "searching for blockbuster drugs," instead of joining "the merger rush sweeping the pharmaceuticals industry." The reporter looks at the Merck's innovative research for painkilling drugs, and describes the effectiveness and the flaws of some of the company's new pills.

This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   info@ire.org   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram